Beth Bioinformatics Co., Ltd (BethBio) is registered in Hong Kong in the area of biotechnology. The company develops state-of-the-art technology for precision medicine in pharmaceutical bioinformatics for optimal vaccine antigen design, and early screening of complex diseases by omics health datasets. BethBio’s R & D is based on solid science and validated findings, empowered by statistics and computational biology. Located in the epicenter of human seasonal influenza, BethBio visions to provide accurate vaccine solution for the world. The company collaborates closely with pharmaceutical companies, health organizations and hospitals on new technology translation.